chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Dyspnoea, Glycosylated haemoglobin increased, Hypoxia
Clinical narrative: COVID+ 11/11/22 - Vaccination status - moderna x3   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 11/11/2022 Discharge Date: 11/13/2022    Active Hospital Problems   Diagnosis Date Noted POA ? COVID 11/11/2022 Yes ? Chronic systolic heart failure (HCC) 11/11/2022 Yes ? History of atrial fibrillation 05/04/2020 Yes ? Anxiety and depression 12/03/2019 Yes ? Hyperlipidemia 10/02/2019 Yes ? BPH (benign prostatic hyperplasia) 10/02/2019 Yes ? Morbid obesity (HCC) 03/28/2018 Yes ? Type 2 diabetes mellitus with complication, without long-term current use of insulin (HCC) 03/28/2018 Yes   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia  Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) COVID-19   HOSPITAL COURSE: 73-year-old gentleman with known history of diabetes atrial fibrillation presents to the emergency department with worsening shortness of breath.  Patient also with increased cough.  Patient diagnosed with COVID-19 in the emergency department.  Patient had received his vaccinations up to the 1st booster.  Patient had a low-grade temperature tachycardic increased respiratory rate on presentation.  Oxygen saturations were 78% on room air.  Patient was placed on 3 L per nasal cannula admitted to the hospital.  He was given Decadron.  There was also some concerns about possible mild pulmonary edema on presentation.  CT angiogram was done coming in which did show bronchial wall thickening but no evidence of PE.     Over the next 2 days patient's respiratory status improved significantly.  He was able to be weaned from room air.  Patient was anxious for discharge to home.  Since his clinical conditions has stabilized going to be discharged home.   Of note patient had elevated blood sugars are hospitalization most likely 2nd to steroids.  His hemoglobin A1 c has increased to 11.2 from 9.8 prior.  Patient does admit to drinking regular soda pop frequently at home.  He also does not check his blood sugars.  Patient was previously on metformin but was unable to tolerate.  He states a caused him diarrhea.  He currently is on Actos.  We discussed that is Actos may be contributing to his lower extremity edema.  We also discussed that he should  follow-up with his primary care physician to discuss appropriate medications to start on as an outpatient.  Patient is hesitant to want to be taking insulin.   Patient also had cardiomegaly on CT scan.  Wife asked about a. Patient did have an echocardiogram ordered in August.  Both him and his wife for unaware that this was ordered.  They been encouraged to follow-up with primary care back to get a repeat echo done.   At the time of discharge all questions have been answered.  Of course of patient's worsening shortness of breath develops high fevers chills or feels his clinical condition is deteriorating anyway he should call his primary care physician or return to the emergency department immediately for further evaluation.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Oedema peripheral, Respiratory rate increased, Sepsis, Tachycardia
Clinical narrative: COVID+ 11/11/22 - Vaccination status - moderna x3   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 11/11/2022 Discharge Date: 11/13/2022    Active Hospital Problems   Diagnosis Date Noted POA ? COVID 11/11/2022 Yes ? Chronic systolic heart failure (HCC) 11/11/2022 Yes ? History of atrial fibrillation 05/04/2020 Yes ? Anxiety and depression 12/03/2019 Yes ? Hyperlipidemia 10/02/2019 Yes ? BPH (benign prostatic hyperplasia) 10/02/2019 Yes ? Morbid obesity (HCC) 03/28/2018 Yes ? Type 2 diabetes mellitus with complication, without long-term current use of insulin (HCC) 03/28/2018 Yes   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia  Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) COVID-19   HOSPITAL COURSE: 73-year-old gentleman with known history of diabetes atrial fibrillation presents to the emergency department with worsening shortness of breath.  Patient also with increased cough.  Patient diagnosed with COVID-19 in the emergency department.  Patient had received his vaccinations up to the 1st booster.  Patient had a low-grade temperature tachycardic increased respiratory rate on presentation.  Oxygen saturations were 78% on room air.  Patient was placed on 3 L per nasal cannula admitted to the hospital.  He was given Decadron.  There was also some concerns about possible mild pulmonary edema on presentation.  CT angiogram was done coming in which did show bronchial wall thickening but no evidence of PE.     Over the next 2 days patient's respiratory status improved significantly.  He was able to be weaned from room air.  Patient was anxious for discharge to home.  Since his clinical conditions has stabilized going to be discharged home.   Of note patient had elevated blood sugars are hospitalization most likely 2nd to steroids.  His hemoglobin A1 c has increased to 11.2 from 9.8 prior.  Patient does admit to drinking regular soda pop frequently at home.  He also does not check his blood sugars.  Patient was previously on metformin but was unable to tolerate.  He states a caused him diarrhea.  He currently is on Actos.  We discussed that is Actos may be contributing to his lower extremity edema.  We also discussed that he should  follow-up with his primary care physician to discuss appropriate medications to start on as an outpatient.  Patient is hesitant to want to be taking insulin.   Patient also had cardiomegaly on CT scan.  Wife asked about a. Patient did have an echocardiogram ordered in August.  Both him and his wife for unaware that this was ordered.  They been encouraged to follow-up with primary care back to get a repeat echo done.   At the time of discharge all questions have been answered.  Of course of patient's worsening shortness of breath develops high fevers chills or feels his clinical condition is deteriorating anyway he should call his primary care physician or return to the emergency department immediately for further evaluation.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Death on 11/11/2022
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal distension, Chills, Eating disorder, Gastrointestinal disorder, Laboratory test
Clinical narrative: I have been having fever, chills, gastrointestinal issues. I have been using hot and cold packs on my arm as it has been extremely sore. I have been coughing with mucus production, chest congestion, using my inhaler to help me breathe when I need it. I have used a home COVID-19 test twice that has come back negative. My GI doctor did prescribe me hyoscyamine 0.1mg to help with the gastrointestinal issues, I am also taking ZOFRAN to help with the nausea. Currently I am feeling bloated, nauseated, trying to eat but I feel crampy. I am waiting on the doctor to call me to give me the test results of the lab work.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Muscle spasms, Nausea, Pain in extremity, Productive cough, Pyrexia
Clinical narrative: I have been having fever, chills, gastrointestinal issues. I have been using hot and cold packs on my arm as it has been extremely sore. I have been coughing with mucus production, chest congestion, using my inhaler to help me breathe when I need it. I have used a home COVID-19 test twice that has come back negative. My GI doctor did prescribe me hyoscyamine 0.1mg to help with the gastrointestinal issues, I am also taking ZOFRAN to help with the nausea. Currently I am feeling bloated, nauseated, trying to eat but I feel crampy. I am waiting on the doctor to call me to give me the test results of the lab work.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: I have been having fever, chills, gastrointestinal issues. I have been using hot and cold packs on my arm as it has been extremely sore. I have been coughing with mucus production, chest congestion, using my inhaler to help me breathe when I need it. I have used a home COVID-19 test twice that has come back negative. My GI doctor did prescribe me hyoscyamine 0.1mg to help with the gastrointestinal issues, I am also taking ZOFRAN to help with the nausea. Currently I am feeling bloated, nauseated, trying to eat but I feel crampy. I am waiting on the doctor to call me to give me the test results of the lab work.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 34.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: about an hour after vaccine administered arm was sore. around 1800, the injection site was hot to the touch, red, bumpy texture, rash, firm, and arm was sore. I did several arm circles throughout the day to help prevent discomfort. On Saturday 11/12, the injection site redness, bumpiness, warm to touch, and firmness spread larger on the upper arm, it continued to be sore, and started to itch significantly. On Sunday 11/13, arm was more itchy, more red rash, hot to touch , firmness, and bumpiness spread more on the arm. Motrin taken on Sunday afternoon. 11/14 & 11/15 the arm was still sore, redness lightened in color somewhat, still itchy, firm but less surface area
Age: 34.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Injection site warmth, Pain in extremity
Clinical narrative: about an hour after vaccine administered arm was sore. around 1800, the injection site was hot to the touch, red, bumpy texture, rash, firm, and arm was sore. I did several arm circles throughout the day to help prevent discomfort. On Saturday 11/12, the injection site redness, bumpiness, warm to touch, and firmness spread larger on the upper arm, it continued to be sore, and started to itch significantly. On Sunday 11/13, arm was more itchy, more red rash, hot to touch , firmness, and bumpiness spread more on the arm. Motrin taken on Sunday afternoon. 11/14 & 11/15 the arm was still sore, redness lightened in color somewhat, still itchy, firm but less surface area
Age: 1.58
Sex: M
Vaccine: FLU4
Symptoms: Injection site swelling
Clinical narrative: right thigh swelling for 1 day
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Decreased appetite, Dyspnoea, General physical health deterioration
Clinical narrative: pt to ED with c/o SOB x 5 days that is worsening; productive cough, sore throat, loss of appetite; O2 supplementation; found to be positive for COVID; given Albuterol and Dexamethasone, Zinc, Vitamin C and D; pt's condition worsened; transitioned to DNR; continued to decline clinically; pt passed away in the hospital
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Productive cough, SARS-CoV-2 test positive
Clinical narrative: pt to ED with c/o SOB x 5 days that is worsening; productive cough, sore throat, loss of appetite; O2 supplementation; found to be positive for COVID; given Albuterol and Dexamethasone, Zinc, Vitamin C and D; pt's condition worsened; transitioned to DNR; continued to decline clinically; pt passed away in the hospital
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: No adverse events noted... Pt. had mixed initial series - the facility was out of Novavax vaccine and pfizer was given
Age: 18.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Pfizer BV and should have received Pfizer MV, as it was his first vaccine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Fibronectin normal, Foetal non-stress test, Headache
Clinical narrative: Admission Date: 11/7/2022 Discharge Date: 11/9/2022 COVID positive date on 10/22/2022, recheck on 11/7/2022 and was COVID positive. Dr. Attending discharge note: PROCEDURES PERFORMED:   none HOSPITAL COURSE: A 27 y.o. G3P2002 female at 32w3d with Estimated Date of Delivery: 12/30/22 dated by 1st trimester ultrasound who presented to triage on 11/7 with generalized malaise, fever, muscle aches, and congestion. Her children were also feeling sick. On presentation she was also having and feeling painful contractions. There was no vaginal bleeding or loss of fluid.  She previously was diagnosed with COVID 19 two weeks prior. She completed 4 days of therapy with lovenox. Temperature was noted to be 38.8 C. Respiratory pathogen fil array was positive for influenza A. She was admitted for inpatient supportive treatment and continuous monitoring of contractions. She was started on Tamiflu 75 mg every 12 hours to complete for a total of 5 days. Cervical exam on admission was 0/30/-3. This remained unchanged and contractions resolved. FFN was negative. She did not required supplemental oxygen during stays and vital signs remained stable. She was discharge after hospital stay #2 and >24 hours without a fever in clinically stable condition. She has already received a COVID 19 booster and the flu vaccination during current pregnancy. She already has a follow up in our office scheduled for 11/11 and she plans to attend.   OB note from admission ASSESSMENT / PLAN: a 27 y.o. G3P2002 female at 32w3d who presents with: Principal Problem:   Influenza A virus present   Plan: 1. Influenza A  - Presented to OB triage for fever, body aches, congestion - symptoms started yesterday night - Positive on respiratory pathogen film array, negative for all other tested pathogens - previously COVID+ 2 weeks ago (10/21/22)   - Plan: - Admit to labor and delivery for continuous monitoring and supportive care - IV access - General diet - Tamiflu 75mg BID x 5 days    2. Preterm contractions - ctx q 4-5 minutes, palpate mild  - SVE 0/30/-3 - FFN negative    3. Fetal well being: - Continuous EFM              - Fetal status currently reassuring              - Baseline 130 bpm, moderate variability, + accels, no decels - 10/17: anterior placenta, cephalic presentation, EFW 1697g 91%, AC 89%, AFI 26.92cm - Polyhydramnios               - 10/31 AFI 28.27cm - NIPT low risk male  results: IMPRESSION:    The exam was limited to evaluation of AFI at 31w3d.  The AFI is c/w mild poly at 28.27 cm.  Patient sees, Certified Mid-Wife for Prenatal visits
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Influenza A virus test positive, Malaise, Maternal exposure before pregnancy, Myalgia
Clinical narrative: Admission Date: 11/7/2022 Discharge Date: 11/9/2022 COVID positive date on 10/22/2022, recheck on 11/7/2022 and was COVID positive. Dr. Attending discharge note: PROCEDURES PERFORMED:   none HOSPITAL COURSE: A 27 y.o. G3P2002 female at 32w3d with Estimated Date of Delivery: 12/30/22 dated by 1st trimester ultrasound who presented to triage on 11/7 with generalized malaise, fever, muscle aches, and congestion. Her children were also feeling sick. On presentation she was also having and feeling painful contractions. There was no vaginal bleeding or loss of fluid.  She previously was diagnosed with COVID 19 two weeks prior. She completed 4 days of therapy with lovenox. Temperature was noted to be 38.8 C. Respiratory pathogen fil array was positive for influenza A. She was admitted for inpatient supportive treatment and continuous monitoring of contractions. She was started on Tamiflu 75 mg every 12 hours to complete for a total of 5 days. Cervical exam on admission was 0/30/-3. This remained unchanged and contractions resolved. FFN was negative. She did not required supplemental oxygen during stays and vital signs remained stable. She was discharge after hospital stay #2 and >24 hours without a fever in clinically stable condition. She has already received a COVID 19 booster and the flu vaccination during current pregnancy. She already has a follow up in our office scheduled for 11/11 and she plans to attend.   OB note from admission ASSESSMENT / PLAN: a 27 y.o. G3P2002 female at 32w3d who presents with: Principal Problem:   Influenza A virus present   Plan: 1. Influenza A  - Presented to OB triage for fever, body aches, congestion - symptoms started yesterday night - Positive on respiratory pathogen film array, negative for all other tested pathogens - previously COVID+ 2 weeks ago (10/21/22)   - Plan: - Admit to labor and delivery for continuous monitoring and supportive care - IV access - General diet - Tamiflu 75mg BID x 5 days    2. Preterm contractions - ctx q 4-5 minutes, palpate mild  - SVE 0/30/-3 - FFN negative    3. Fetal well being: - Continuous EFM              - Fetal status currently reassuring              - Baseline 130 bpm, moderate variability, + accels, no decels - 10/17: anterior placenta, cephalic presentation, EFW 1697g 91%, AC 89%, AFI 26.92cm - Polyhydramnios               - 10/31 AFI 28.27cm - NIPT low risk male  results: IMPRESSION:    The exam was limited to evaluation of AFI at 31w3d.  The AFI is c/w mild poly at 28.27 cm.  Patient sees, Certified Mid-Wife for Prenatal visits
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sick relative
Clinical narrative: Admission Date: 11/7/2022 Discharge Date: 11/9/2022 COVID positive date on 10/22/2022, recheck on 11/7/2022 and was COVID positive. Dr. Attending discharge note: PROCEDURES PERFORMED:   none HOSPITAL COURSE: A 27 y.o. G3P2002 female at 32w3d with Estimated Date of Delivery: 12/30/22 dated by 1st trimester ultrasound who presented to triage on 11/7 with generalized malaise, fever, muscle aches, and congestion. Her children were also feeling sick. On presentation she was also having and feeling painful contractions. There was no vaginal bleeding or loss of fluid.  She previously was diagnosed with COVID 19 two weeks prior. She completed 4 days of therapy with lovenox. Temperature was noted to be 38.8 C. Respiratory pathogen fil array was positive for influenza A. She was admitted for inpatient supportive treatment and continuous monitoring of contractions. She was started on Tamiflu 75 mg every 12 hours to complete for a total of 5 days. Cervical exam on admission was 0/30/-3. This remained unchanged and contractions resolved. FFN was negative. She did not required supplemental oxygen during stays and vital signs remained stable. She was discharge after hospital stay #2 and >24 hours without a fever in clinically stable condition. She has already received a COVID 19 booster and the flu vaccination during current pregnancy. She already has a follow up in our office scheduled for 11/11 and she plans to attend.   OB note from admission ASSESSMENT / PLAN: a 27 y.o. G3P2002 female at 32w3d who presents with: Principal Problem:   Influenza A virus present   Plan: 1. Influenza A  - Presented to OB triage for fever, body aches, congestion - symptoms started yesterday night - Positive on respiratory pathogen film array, negative for all other tested pathogens - previously COVID+ 2 weeks ago (10/21/22)   - Plan: - Admit to labor and delivery for continuous monitoring and supportive care - IV access - General diet - Tamiflu 75mg BID x 5 days    2. Preterm contractions - ctx q 4-5 minutes, palpate mild  - SVE 0/30/-3 - FFN negative    3. Fetal well being: - Continuous EFM              - Fetal status currently reassuring              - Baseline 130 bpm, moderate variability, + accels, no decels - 10/17: anterior placenta, cephalic presentation, EFW 1697g 91%, AC 89%, AFI 26.92cm - Polyhydramnios               - 10/31 AFI 28.27cm - NIPT low risk male  results: IMPRESSION:    The exam was limited to evaluation of AFI at 31w3d.  The AFI is c/w mild poly at 28.27 cm.  Patient sees, Certified Mid-Wife for Prenatal visits
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound foetal, Uterine contractions during pregnancy, Vision blurred
Clinical narrative: Admission Date: 11/7/2022 Discharge Date: 11/9/2022 COVID positive date on 10/22/2022, recheck on 11/7/2022 and was COVID positive. Dr. Attending discharge note: PROCEDURES PERFORMED:   none HOSPITAL COURSE: A 27 y.o. G3P2002 female at 32w3d with Estimated Date of Delivery: 12/30/22 dated by 1st trimester ultrasound who presented to triage on 11/7 with generalized malaise, fever, muscle aches, and congestion. Her children were also feeling sick. On presentation she was also having and feeling painful contractions. There was no vaginal bleeding or loss of fluid.  She previously was diagnosed with COVID 19 two weeks prior. She completed 4 days of therapy with lovenox. Temperature was noted to be 38.8 C. Respiratory pathogen fil array was positive for influenza A. She was admitted for inpatient supportive treatment and continuous monitoring of contractions. She was started on Tamiflu 75 mg every 12 hours to complete for a total of 5 days. Cervical exam on admission was 0/30/-3. This remained unchanged and contractions resolved. FFN was negative. She did not required supplemental oxygen during stays and vital signs remained stable. She was discharge after hospital stay #2 and >24 hours without a fever in clinically stable condition. She has already received a COVID 19 booster and the flu vaccination during current pregnancy. She already has a follow up in our office scheduled for 11/11 and she plans to attend.   OB note from admission ASSESSMENT / PLAN: a 27 y.o. G3P2002 female at 32w3d who presents with: Principal Problem:   Influenza A virus present   Plan: 1. Influenza A  - Presented to OB triage for fever, body aches, congestion - symptoms started yesterday night - Positive on respiratory pathogen film array, negative for all other tested pathogens - previously COVID+ 2 weeks ago (10/21/22)   - Plan: - Admit to labor and delivery for continuous monitoring and supportive care - IV access - General diet - Tamiflu 75mg BID x 5 days    2. Preterm contractions - ctx q 4-5 minutes, palpate mild  - SVE 0/30/-3 - FFN negative    3. Fetal well being: - Continuous EFM              - Fetal status currently reassuring              - Baseline 130 bpm, moderate variability, + accels, no decels - 10/17: anterior placenta, cephalic presentation, EFW 1697g 91%, AC 89%, AFI 26.92cm - Polyhydramnios               - 10/31 AFI 28.27cm - NIPT low risk male  results: IMPRESSION:    The exam was limited to evaluation of AFI at 31w3d.  The AFI is c/w mild poly at 28.27 cm.  Patient sees, Certified Mid-Wife for Prenatal visits
Age: 10.0
Sex: M
Vaccine: FLUC4
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: red, swollen site of injection starting the evening after administration. seen the following day and assessed in the office, referred to allergy specialist.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Dehydration, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: pt brought to ED from facility with sacral wound, found to have UTI and is dehydrated; O2 supplementation; IV fluids given; wound care; pt dc'd back to facility; on day of discharge pt tested positive for COVID; pt passed away in the facility.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Wound
Clinical narrative: pt brought to ED from facility with sacral wound, found to have UTI and is dehydrated; O2 supplementation; IV fluids given; wound care; pt dc'd back to facility; on day of discharge pt tested positive for COVID; pt passed away in the facility.
Age: 56.0
Sex: F
Vaccine: PNC20
Symptoms: Asthenia, Bone pain, Fatigue, Headache, Influenza like illness
Clinical narrative: Severe headache, all over severe pain, bones ache, weakness, flu like symptoms, fever, extreme fatigue
Age: 56.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Pyrexia
Clinical narrative: Severe headache, all over severe pain, bones ache, weakness, flu like symptoms, fever, extreme fatigue
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Migraine, Somnolence
Clinical narrative: Initially had a lot of sleepiness starting about 8 hours after the vaccine.  This was followed by a moderate to severe headache starting 24 hours after the vaccine which then progressed to a migraine (unclear exactly when) which lasted at least 4-5 days.  Was unable to perform any usual activities for at least 3 days after the vaccine.  Of note, I had similar symptoms after each of the covid vaccines - all Moderna - this was my second Moderna dose.  Symptoms got progressively worse with each shot.  (lasted only 24 hours with the first shot, with only a HA, no migraine).  Recently had the Pfizer covalent booster with minimal adverse effects - felt like a normal vaccine.  Also filed a VAERS report for 3rd Moderna shot.  Only realized that my response was abnormal in retrospect after taking to lots of people about the vaccine.  Of note, as a physician myself and strong proponent of vaccination,  I had significant vaccine hesitancy for the first time given the degree of side effects and hence never got the second booster dose last year.  Pfizer was a "breeze" in comparison......the solution for me.
Age: 47.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bell's palsy, Computerised tomogram abnormal, Facial paralysis
Clinical narrative: Took the 4th Bivalent Pfizer shot on 10/10/2022 and started seeing symptoms of Bell's Palsy on 11/12/2022. Thought was a stroke at first and went to doctor and was recommended to do CT scan at hospital. Did CT scan and was diagnosed with Bell's Palsy. Taking medicines as prescribed. Not sure if Pfizer vaccine has this side effect. But having the left side of the face with no movement is no fun.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given a high dose prior to eligibility. Patient was contacted the following morning to be made aware of the error and as of 11/16/22 @ 10:45 AM she did not have any adverse effects.
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4, COVID19-2, FLUA4
Symptoms: Chest X-ray normal, Dyspnoea, Intensive care, Interstitial lung disease, Palpitations
Clinical narrative: About a day after being vaccinated, he devoloped SOB.  He continued to worsen and was seen at urgent care on 10/10/22. He was provided medication (unknown) but continued to worsen so saw his PCP on 10/20. Dr. gave Rx Methylprednisilone and Trelegy Ellipta on 10/20. He continued to worsen and went to ER on 10/23/22 where he was diagnosed with ILD. He is currently in ICU and not expected to survive. It had reportedly been mentioned to the family that vaccination could have precipitated this event. He also received influenza vaccine on 9/28 at same pharmacy but family did not have vaccine info
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4, COVID19-2, FLUA4
Symptoms: Pulmonary fibrosis
Clinical narrative: About a day after being vaccinated, he devoloped SOB.  He continued to worsen and was seen at urgent care on 10/10/22. He was provided medication (unknown) but continued to worsen so saw his PCP on 10/20. Dr. gave Rx Methylprednisilone and Trelegy Ellipta on 10/20. He continued to worsen and went to ER on 10/23/22 where he was diagnosed with ILD. He is currently in ICU and not expected to survive. It had reportedly been mentioned to the family that vaccination could have precipitated this event. He also received influenza vaccine on 9/28 at same pharmacy but family did not have vaccine info
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4, COVID19-2, FLUA4
Symptoms: Chest X-ray normal, Dyspnoea, Intensive care, Interstitial lung disease, Palpitations
Clinical narrative: Patient's brother and sister in law  came to the pharmacy this morning inquiring about the Moderna Bivalent Booster and Fluad he received on 9/28/22.  Patient's brother said that the day after his brother had his IMZ series he started having difficulty in breathing and palpitations. He went into a walk in clinic on 10/10/22 and the prescriber gave him a script of prednisone, azithromycin, and benzonatate.  He saw his primary care on 10/20/22, had chest x-rays which were negative for pneumonia, and was given a rx for Medrol DP. He was given a week's supply of furosemide the next day.   Patient has been in the hospital for the last 18 days and in the ICU recently with interstitial lung disease and pulmonary fibrosis. Patient is in critical care.
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4, COVID19-2, FLUA4
Symptoms: Pulmonary fibrosis
Clinical narrative: Patient's brother and sister in law  came to the pharmacy this morning inquiring about the Moderna Bivalent Booster and Fluad he received on 9/28/22.  Patient's brother said that the day after his brother had his IMZ series he started having difficulty in breathing and palpitations. He went into a walk in clinic on 10/10/22 and the prescriber gave him a script of prednisone, azithromycin, and benzonatate.  He saw his primary care on 10/20/22, had chest x-rays which were negative for pneumonia, and was given a rx for Medrol DP. He was given a week's supply of furosemide the next day.   Patient has been in the hospital for the last 18 days and in the ICU recently with interstitial lung disease and pulmonary fibrosis. Patient is in critical care.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: no ADR at all, gave primary moderna rather than booster
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Feeling abnormal, Nasal discomfort, Oropharyngeal pain
Clinical narrative: My sinuses were burning really bad, I had thought it was from the dry air and cigarettes from being in a dry climate. A couple of days later I got a sore throat and cough. I did an at home COVID-19 test that came back negative. After a couple of days of feeling bad and my at home COVID-19 test coming back negative I went to the doctor. My doctor did a rapid COVID-19 test that came back positive. He prescribed me some benzonatate for the cough. I started to feel better in five days and tested negative on 06/0/2022.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: My sinuses were burning really bad, I had thought it was from the dry air and cigarettes from being in a dry climate. A couple of days later I got a sore throat and cough. I did an at home COVID-19 test that came back negative. After a couple of days of feeling bad and my at home COVID-19 test coming back negative I went to the doctor. My doctor did a rapid COVID-19 test that came back positive. He prescribed me some benzonatate for the cough. I started to feel better in five days and tested negative on 06/0/2022.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Tachycardia
Clinical narrative: Pt c/o tachycardia and numbness in hand 10 min after vaccination. VS: 120/72 HR76 O2 Sat 100% EMS called VS stable. Declined transport to hospital ED. Encouraged to follow up with PCP.  Made it home on own uneventfully.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: I had a sore throat, runny nose with a headache. A slight fever with minor coughing.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: I had a sore throat, runny nose with a headache. A slight fever with minor coughing.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site discharge, Injection site haemorrhage, Injection site pain, Product administration error, Underdose
Clinical narrative: There was an administration error. The Pharmacist gave the injection which was unusually painful. When she applied the  bandaid, the pressure caused liquid to be expelled ( blood or vaccine.  She jumped, made an audible sound of surprise, then wiped the dripping substance that was running down my arm.  Within an hour the area around the injection site was extremely sore.  The next morning when I removed the bandaid, there were multiple (3?) small blood spots on it.  But, concerning, some clear  liquid seemed to have run through them leaving some streaking!  None of the customary tiredness on the 2nd or 3rd day following the booster.   I am certain I did not get a full dose.  I need to determine if I should repeat!
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Approximately one month after getting my vaccination I developed COVID-19. On 11/12 I began having a tickle in my throat that evening. On 11/13 I woke up with a worse sore throat, fatigue, and congestion. Tested positive on an at home COVID-19 and reached out to PCP. Prescribed steroids and an antiviral. Prescriptions have helped resolve symptoms but some are still lingering.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Throat irritation
Clinical narrative: Approximately one month after getting my vaccination I developed COVID-19. On 11/12 I began having a tickle in my throat that evening. On 11/13 I woke up with a worse sore throat, fatigue, and congestion. Tested positive on an at home COVID-19 and reached out to PCP. Prescribed steroids and an antiviral. Prescriptions have helped resolve symptoms but some are still lingering.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: ASYMPTOMATIC
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray, Chills, Cough
Clinical narrative: Admitted on 11/15 for weakness. Tested positive for COVID 19. Symptoms started 11/12/22- cough, chills, and lightheadedness.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, SARS-CoV-2 test positive
Clinical narrative: Admitted on 11/15 for weakness. Tested positive for COVID 19. Symptoms started 11/12/22- cough, chills, and lightheadedness.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Exercise tolerance decreased
Clinical narrative: About a month after I started having difficulty breathing and chest pain.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Printed label used to put on form was mis-marked as bivalent, It was actually monovalent.  Bivalent should have been given
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Electrocardiogram normal, Fibrin D dimer normal, Pyrexia
Clinical narrative: PRESENTING PROBLEM: Weakness   HOSPITAL COURSE: Patient is a 61-year-old male who was admitted on 11/11 for observation a weakness to work with PT and OT.  Patient was found to still be COVID-19 positive.   Recent medical history was that patient 1st became COVID-19 positive on 9/19 admitted for weakness related to this and discharged 9/24. Returned 10/04 admitted at hospital for bacterial pneumonia transferred to other facility for bronchoscopy, discharged to subacute rehab on 10/13.   Returned with weakness and intermittent fevers for the past 2 weeks. We consulted with ID who believes the COVID positive this admission is DNA fragments detected has cycle threshold was high consistent with a cleared infection.   Patient feels stronger, he has been eating and drinking well. He has been working closely with therapy team and initially they were recommending subacute rehab but today changing to home with home health care, PT, & OT.   Patient feels ready to go, vitals are stable though he has some mild tachycardia (ECG normal sinus, D-dimer is normal, no leukocytosis or fevers during admission). No changes to patient's chronic medications at discharge.   CONSULTS / RECOMMENDATION: See Infectious Disease Doctor's note on 11/15   Physical Exam at Discharge Temp 36.6°, heart rate 107, blood pressure 110/75, respiratory 18, oxygenation 92% on room air   Physical Exam Constitutional: Well nourished, no acute distress. Alert and oriented to person, place and time. Answering questions appropriately. Cardiovascular: Mild and regular rhythm. Pulmonary/Chest: Unlabored speech and respirations on room air. No use of accessory muscles. Clear lung sounds with no crackles or wheezes. Musculoskeletal: Moving all four extremities spontaneously. Integumentary: Warm, pink, and dry.  Neurological: No gross motor or sensory deficits.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Tachycardia, Viral upper respiratory tract infection
Clinical narrative: PRESENTING PROBLEM: Weakness   HOSPITAL COURSE: Patient is a 61-year-old male who was admitted on 11/11 for observation a weakness to work with PT and OT.  Patient was found to still be COVID-19 positive.   Recent medical history was that patient 1st became COVID-19 positive on 9/19 admitted for weakness related to this and discharged 9/24. Returned 10/04 admitted at hospital for bacterial pneumonia transferred to other facility for bronchoscopy, discharged to subacute rehab on 10/13.   Returned with weakness and intermittent fevers for the past 2 weeks. We consulted with ID who believes the COVID positive this admission is DNA fragments detected has cycle threshold was high consistent with a cleared infection.   Patient feels stronger, he has been eating and drinking well. He has been working closely with therapy team and initially they were recommending subacute rehab but today changing to home with home health care, PT, & OT.   Patient feels ready to go, vitals are stable though he has some mild tachycardia (ECG normal sinus, D-dimer is normal, no leukocytosis or fevers during admission). No changes to patient's chronic medications at discharge.   CONSULTS / RECOMMENDATION: See Infectious Disease Doctor's note on 11/15   Physical Exam at Discharge Temp 36.6°, heart rate 107, blood pressure 110/75, respiratory 18, oxygenation 92% on room air   Physical Exam Constitutional: Well nourished, no acute distress. Alert and oriented to person, place and time. Answering questions appropriately. Cardiovascular: Mild and regular rhythm. Pulmonary/Chest: Unlabored speech and respirations on room air. No use of accessory muscles. Clear lung sounds with no crackles or wheezes. Musculoskeletal: Moving all four extremities spontaneously. Integumentary: Warm, pink, and dry.  Neurological: No gross motor or sensory deficits.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient came in for covid-19 booster patient was to receive bivalent but nurse accidentally pulled monovalent. Patient was then given the vaccination. Later that evening at 4:45 Nurse manager called and informed nurse that monovalent was given instead if bivalent. Patient notified the next day on 11/16/2022 that he was given monovalent instead of bivalent and patient needs to come back into clinic to receive bivalent booster. Patient was accepting at this time.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Chills, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Rash at injection site, followed by fever and chills through the night. Swelling and soreness at injection site and mild bronchitis following day.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Rash at injection site, followed by fever and chills through the night. Swelling and soreness at injection site and mild bronchitis following day.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy test negative, Eye irritation, Eye pruritus
Clinical narrative: I have been having significant burning and itching in my eyes. I assumed it was due to allergies, but I have been tested and it is not. It is irregular and hard to track cause. I did not think it could be related to the vaccine, then I was reminded this didn't start until after the vaccine.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent was drawn and given as booster dose, mistaken for pfizer covid bivlanet
Age: 52.0
Sex: M
Vaccine: FLUA4
Symptoms: Arthralgia, Pain
Clinical narrative: Upon waking up Saturday 11/12/22 @ 8 am. Body aches in joints and especially in right knee which I suffer injury years ago.  I didn't notice swollen in the beginning. I kept resting and hopefully it will pass. Went to my dentist visit.  Tuesday morning, the pain became worse. Tried elevating my leg and put icepack.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Adult failure to thrive, Anticoagulant therapy, Asthenia, COVID-19
Clinical narrative: 2/11/22 pt brought to the hospital with generalized weakness, poor oral intake, less alert, coughing over the past week; found to be positive for COVID and UTI; admitted to ICU; respiratory status without distress; given ABX; DNR; acute on chronic renal failure, failure to thrive, sepsis; DVT in right upper extremity, started Heparin drip; pt eventually dc'd to home 2/19/22 where she passed away
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Death, Deep vein thrombosis, Depressed level of consciousness, Hypophagia
Clinical narrative: 2/11/22 pt brought to the hospital with generalized weakness, poor oral intake, less alert, coughing over the past week; found to be positive for COVID and UTI; admitted to ICU; respiratory status without distress; given ABX; DNR; acute on chronic renal failure, failure to thrive, sepsis; DVT in right upper extremity, started Heparin drip; pt eventually dc'd to home 2/19/22 where she passed away
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, SARS-CoV-2 test positive, Sepsis, Urinary tract infection, Urine analysis abnormal
Clinical narrative: 2/11/22 pt brought to the hospital with generalized weakness, poor oral intake, less alert, coughing over the past week; found to be positive for COVID and UTI; admitted to ICU; respiratory status without distress; given ABX; DNR; acute on chronic renal failure, failure to thrive, sepsis; DVT in right upper extremity, started Heparin drip; pt eventually dc'd to home 2/19/22 where she passed away
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient given bivalent instead of second dose in inital series. No adverse effect reported or noted. Date of first vaccine was 10-26-2022
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Dose #1 of Moderna COVID-19 6m - 5 yr given on 7/19/22 and tolerated well. Dose # 2 Moderna COVID-19 6m-5yr given on 8/9/22 (Three days earlier than grace period and 1 week prior to recommended interval date due to a scheduling error)- No adverse events reported.   Re-education provided to scheduling staff and nurses. Posted reminders to double check dosing intervals. Mother made aware of scheduling error and recommendation to revaccinate. Appointment scheduled.
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Extra dose administered
Clinical narrative: Patient was given immunizations, Tdap, Meningitis ACWY, and HPV vaccines. Spoke to mother on 11/11/22, and she informed me that patient had already received a Tdap on 4/26/22.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 17.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Expired product administered, Incorrect product formulation administered
Clinical narrative: Patient received a monovalent instead of the bivalent for a booster. Monovalent does was also expired on 11/4/2022 which is outside of the 10 week refrigeration date. Dose was given on 11/11/2022
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Oropharyngeal pain, Pain
Clinical narrative: I did not have a reaction to the vaccine. I tested positive for COVID-19 with a home test on 09/06/2022 without prior symptoms. I had a sore throat and a fever. I got a PCR test at my doctor's office which was positive for COVID-19. My doctor recommended aspirin and ibuprofen for the fever. I was given a prescription for PAXLOVID but never got it filled. The fever, sore throat, aches and chills lasted for three days. The fatigue and grogginess lasted about fifteen days.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Somnolence
Clinical narrative: I did not have a reaction to the vaccine. I tested positive for COVID-19 with a home test on 09/06/2022 without prior symptoms. I had a sore throat and a fever. I got a PCR test at my doctor's office which was positive for COVID-19. My doctor recommended aspirin and ibuprofen for the fever. I was given a prescription for PAXLOVID but never got it filled. The fever, sore throat, aches and chills lasted for three days. The fatigue and grogginess lasted about fifteen days.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, SARS-CoV-2 test, Upper respiratory tract infection
Clinical narrative: I had a sore throat and felt like i have an upper respitory infection. I felt really wore out.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: I woke up in the morning and I felt very bad upon arriving at my School where I work was tested for COVID-19 and my test was positive.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Medication error, No adverse event
Clinical narrative: This is not an adverse event, this was a med error that occurred in which the patient received the monovalent vaccine when it was the bivalent vaccine that was intended.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent covid vaccine administered as bivalent, pt. notified and advised to repeat bivalent booster => 2 months